Emcure Pharmaceuticals Ltd Share Price
(EMCURE)
₹927.7▲0.23%
as on 04:01PM, 13 Mar 2025
Emcure Pharmaceuticals Ltd Performance
Day's Low
Day's High
₹916.75Day's Price Range₹944.0552 Week's Low
52 Week's High
₹916.7552-Week Price Range₹1,580
| Returns % | |
| 1 Month Return | -3.36 % |
| 3 Month Return | -34.15 % |
| 1 Year Return | -31.74 % |
| Market Stats | |
| Previous Close | ₹925.55 |
| Open | ₹931.00 |
| Volume | 82.30K |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹17,573.59Cr |
Emcure Pharmaceuticals Ltd Key Statistics
P/E Ratio
28.4
PEG Ratio
2.47
Market Cap
₹17,573.59 Cr
P/B Ratio
0EPS
0Dividend Yield
0Sector
Pharmaceuticals
ROE
8.52
Emcure Pharmaceuticals Ltd Mutual Fund Holdings
Emcure Pharmaceuticals Ltd Analyst Rating
based on 3 analysts
66.67%
Buy
33.33%
Hold
0.00%
Sell
Based on 3 analysts offering long term price targets for Emcure Pharmaceuticals Ltd. An average target of ₹1535
Source: S&P Global Market Intelligence
Emcure Pharmaceuticals Ltd Share analysis
Emcure Pharmaceuticals Ltd price forecast by 3 analysts
Upside of65.46%
High
₹1650
Target
₹1535.00
Low
₹1440
Emcure Pharmaceuticals Ltd target price ₹1535, a slight upside of 65.46% compared to current price of ₹927.7. According to 3 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Emcure Pharmaceuticals Ltd revenue growth forecast
Expected growth rate Q1, FY2027:0
Forecast
Actual
Including amortisation and stock based compensations
Emcure Pharmaceuticals Ltd EPS growth forecast
EPS estimate Q1, FY2027:0
Forecast
Actual
Source: S&P Global Market Intelligence
Key events for Emcure Pharmaceuticals Ltd
Emcure Pharmaceuticals Launches Daily Supplements Range - 10 Mar, 2025
Emcure Pharmaceuticals enters the daily supplements market with its Arth range, featuring products for women's health. The brand partners with actress Vidya Balan to promote key health issues.Emcure Pharmaceuticals Receives USFDA Observations - 26 Feb, 2025
Emcure Pharmaceuticals announced that its API manufacturing facility received two observations from the USFDA following an inspection. The company is addressing these observations and will respond within the required timeframe.
Insights on Emcure Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRetail Holding Up
Retail Investor have increased holdings from 15.05% to 15.14% in Dec 2024 quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 2.91% to 3.05% in Dec 2024 quarter
NEGATIVE IMPACTPrice Dip
In the last 1 year, EMCURE stock has moved down by -31.7%
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 78.08% to 77.94% in Dec 2024 quarter
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 3.30% to 3.10% in Dec 2024 quarter
Emcure Pharmaceuticals Ltd Financials
Index Inclusions
Emcure Pharmaceuticals Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 77.94% | ||
| Foreign Institutions | 3.05% | 4.85 | |
| Mutual Funds | 3.1% | ||
| Retail Investors | 15.14% | 0.61 | |
| Others | 0.77% | 16.61 |
Emcure Pharmaceuticals Ltd Key Indicators
Emcure Pharmaceuticals Ltd Valuation
Emcure Pharmaceuticals Ltd in the last 5 years
Lowest (28.34x)
March 12, 2025
Today (28.40x)
March 13, 2025
Industry (50.82x)
March 13, 2025
Highest (53.98x)
September 18, 2024
Emcure Pharmaceuticals Ltd Earnings and Dividends
Emcure Pharmaceuticals Ltd Earnings Results
Emcure Pharmaceuticals Ltd’s net profit jumped 35.5% since last year same period to ₹153.72Cr in the Q3 2024-2025. On a quarterly growth basis, Emcure Pharmaceuticals Ltd has generated -21% fall in its net profits since last 3-months.
Read More about Earnings Results
Emcure Pharmaceuticals Ltd Technicals Summary
Bearish
Neutral
Bullish
Emcure Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.
Emcure Pharmaceuticals Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹17,573.59 Cr | -6.35% | 0.73 | ₹527 Cr | ₹6,658 Cr | |
| BUY | ₹8,934.15 Cr | 26.69% | 0.62 | ₹48 Cr | ₹717 Cr | |
| NA | ₹1,228.75 Cr | -7.69% | 0.62 | ₹57 Cr | ₹398 Cr | |
| NA | ₹2,161.57 Cr | 88.29% | 0.56 | -₹15 Cr | ₹180 Cr | |
| NA | ₹96.63 Cr | -9.28% | 0.64 | ₹9 Cr | ₹131 Cr |
About Emcure Pharmaceuticals Ltd
Share Price: ₹927.70 per share as on 13 Mar, 2025 04:01 PM
Market Capitalisation: ₹17,573.59Cr as of today
Revenue: ₹1,962.63Cr as on December 2024 (Q4 24)
Net Profit: ₹156.09Cr as on December 2024 (Q4 24)
Listing date: 10 Jul, 2024
| Organisation | Emcure Pharmaceuticals Ltd |
| Headquarters | |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs on Emcure Pharmaceuticals Ltd
What is Emcure Pharmaceuticals Ltd price today?
Emcure Pharmaceuticals Ltd share price today stands at ₹927.7, Open: ₹931, Previous Close: ₹925.55, High: ₹944.05, Low: ₹916.75, 52 Week High: ₹1580, 52 Week Low: ₹916.75.
How to Buy Emcure Pharmaceuticals Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Emcure Pharmaceuticals Ltd shares
Is Emcure Pharmaceuticals Ltd listed on NSE?
Emcure Pharmaceuticals Ltd is listed on NSE
Is Emcure Pharmaceuticals Ltd listed on BSE?
Emcure Pharmaceuticals Ltd is listed on BSE
What are today's High and Low prices of Emcure Pharmaceuticals Ltd?
- Today's highest price of Emcure Pharmaceuticals Ltd is ₹944.05.
- Today's lowest price of Emcure Pharmaceuticals Ltd is ₹916.75.
What are today's traded volumes of Emcure Pharmaceuticals Ltd?
Today's traded volume of Emcure Pharmaceuticals Ltd(EMCURE) is 82.30K.
What is today's market capitalisation of Emcure Pharmaceuticals Ltd?
Today's market capitalisation of Emcure Pharmaceuticals Ltd(EMCURE) is ₹17573.59Cr.
What is the 52 Week High and Low Range of Emcure Pharmaceuticals Ltd?
How much percentage Emcure Pharmaceuticals Ltd is down from its 52 Week High?
Emcure Pharmaceuticals Ltd (EMCURE) share price is ₹927.7. It is down -41.28% from its 52 Week High price of ₹1580
How much percentage Emcure Pharmaceuticals Ltd is up from its 52 Week low?
Emcure Pharmaceuticals Ltd (EMCURE) share price is ₹927.7. It is up 1.19% from its 52 Week Low price of ₹916.75
What are the historical returns of Emcure Pharmaceuticals Ltd?
What is the PE ratio of Emcure Pharmaceuticals Ltd today?
PE Ratio of Emcure Pharmaceuticals Ltd is 28.4
PE ratio = Emcure Pharmaceuticals Ltd Market price per share / Emcure Pharmaceuticals Ltd Earnings per share